PET scans reveal hidden brain inflammation in rare movement disorder
NCT ID NCT07000851
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study uses advanced PET scans and blood tests to examine brain inflammation and white matter damage in people with corticobasal syndrome, a rare movement and thinking disorder. Researchers will compare these brain changes across different subtypes of the condition and against healthy volunteers. The goal is to better understand the underlying disease processes, which could guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- C-11 ER176 Radiotracer, C-11 PiB, AV1451 Tau (diagnostic PET tracers)
- What this could lead to
- If successful, this study could reveal how inflammation and white matter damage contribute to corticobasal syndrome, potentially pointing toward new treatment targets.
- What could go wrong
- This is an observational imaging study, not a treatment trial. It may not directly lead to therapies, and findings may not apply to all patients with the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORTICO BASAL DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists decode gait signatures to spot brain diseases
- Experimental drug aims to curb disinhibition in dementia patients
- New quick tests may unlock secrets of brain disease
- Smart sensors could revolutionize dementia monitoring at home
- Tiny brain clues may reveal how dementias differ
- Massive brain study aims to catch dementia early